Nephrotic-range proteinuria: a potential risk factor for failure of tixagevimab-cilgavimab prophylaxis.

Ayman Al JurdiChristopher El MouhayyarOrhan EfeAnushya JeyabalanLeonardo V Riella

Published in: Journal of nephrology (2023)

Nephrotic-range proteinuria may increase the risk of failure of tixagevimab-cilgavimab pre-exposure prophylaxis. Prospective studies to validate these findings and to evaluate the optimal dosing strategy of antibody-based prophylaxis in this group of patients are needed.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
risk assessment
climate change
human health
diabetic nephropathy